Top compounds associated with response to FCRLB


Feature Type Standardized
Nominal ANOVA
mRNA IC-87114 CTRPv2 pan-cancer AAC 0.0043 0.9
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.0042 0.9
mRNA docetaxel:tanespimycin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.0036 0.9
mRNA phenformin GDSC1000 pan-cancer AAC -0.0036 0.9
mRNA BRD-K14844214 CTRPv2 pan-cancer AAC -0.0043 0.9
mRNA Vinblastine GDSC1000 pan-cancer AAC 0.0037 0.9
mRNA PD318088 CTRPv2 pan-cancer AAC -0.0034 0.9
mRNA Nutlin-3a (-) GDSC1000 pan-cancer AAC 0.0034 0.9
mRNA Docetaxel CTRPv2 pan-cancer AAC 0.0043 0.9
mRNA SNX-2112 CTRPv2 pan-cancer AAC -0.0028 0.9
Download CSV